FN vs OGN · P/E 61, rev $4.64B vs P/E 3.4, rev $3.02B
Fabrinet (FN) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Fabrinet (FN) is a electronic components company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported FN revenue for 2026-06-26 was $4.64B. Net income was $473.0M. Revenue was up 35.7% from 2025-06-27 to 2026-06-26. FN currently screens at market cap $25.61B and trailing P/E 61.4.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
FN currently screens at market cap $25.61B and trailing P/E 61.4. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the FN and OGN stock pages for the full models.
Not investment advice.